Established in 2015, the Multi-Stakeholder Engagement (MuSE) Consortium is an international network of over 120 individuals interested in stakeholder engagement in research and guidelines. The MuSE group is developing guidance for stakeholder engagement in the development of health and healthcare guideline development. The development of this guidance has included multiple meetings with stakeholders, including patients, payers/purchasers of health services, peer review editors, policymakers, program managers, providers, principal investigators, product makers, the public, and purchasers of health services and has identified a number of key issues. These include: (1) Definitions, roles, and settings (2) Stakeholder identification and selection (3) Levels of engagement, (4) Evaluation of engagement, (5) Documentation and transparency, and (6) Conflict of interest management. In this paper, we discuss these issues and our plan to develop guidance to facilitate stakeholder engagement in all stages of the development of health and healthcare guideline development.
Key issues for stakeholder engagement in the development of health and healthcare guidelines / J. Petkovic, O. Magwood, L. Lytvyn, J. Khabsa, T.W. Concannon, V. Welch, A. Todhunter-Brown, M.E. Palm, E.A. Akl, L. Mbuagbaw, T. Arayssi, M.T. Avey, A. Marusic, R. Morley, M. Saginur, N. Slingers, L. Texeira, A. Ben Brahem, S. Bhaumik, I. Bou Akl, S. Crowe, L. Dormer, C. Ekanem, E. Lang, B. Kianzad, T. Kuchenmüller, L. Moja, K. Pottie, H. Schünemann, P. Tugwell. - In: RESEARCH INVOLVEMENT AND ENGAGEMENT. - ISSN 2056-7529. - 9:1(2023), pp. 27.1-27.10. [10.1186/s40900-023-00433-6]
Key issues for stakeholder engagement in the development of health and healthcare guidelines
L. Moja;
2023
Abstract
Established in 2015, the Multi-Stakeholder Engagement (MuSE) Consortium is an international network of over 120 individuals interested in stakeholder engagement in research and guidelines. The MuSE group is developing guidance for stakeholder engagement in the development of health and healthcare guideline development. The development of this guidance has included multiple meetings with stakeholders, including patients, payers/purchasers of health services, peer review editors, policymakers, program managers, providers, principal investigators, product makers, the public, and purchasers of health services and has identified a number of key issues. These include: (1) Definitions, roles, and settings (2) Stakeholder identification and selection (3) Levels of engagement, (4) Evaluation of engagement, (5) Documentation and transparency, and (6) Conflict of interest management. In this paper, we discuss these issues and our plan to develop guidance to facilitate stakeholder engagement in all stages of the development of health and healthcare guideline development.File | Dimensione | Formato | |
---|---|---|---|
Petkovic_2023.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.18 MB
Formato
Adobe PDF
|
1.18 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.